Triple therapy with octreotide, galanin, and serotonin reduces the size and blood vessel density and increases apoptosis of a rat colon carcinoma

Regulatory Peptides

Volumn 111, Issue 1-3, 2003, Pages 145-152

  El Salhy, Magdy ^a   Sitohy, Basel ^a   Norrgård, Örjan ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenocarcinoma; Colon; Galanin; Octreotide; Serotonin; Therapy

Indexed keywords

GALANIN; OCTREOTIDE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIOLE; ARTICLE; BLOOD VESSEL; BODY WEIGHT; CANCER CELL; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DENSITY; DRUG DOSE REGIMEN; FEMALE; ISCHEMIA; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME; VASOCONSTRICTION;

ANIMALIA; MUS MUSCULUS;

EID: 0037471355     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00280-X     Document Type: Article

References (33)

1. Midgely O.R., Kerr D. Colorectal cancer. Lancet. 353:1999;391-399.
2. Berger T., Eklund G., Mellner C., Phil B., Wenckert A. Carcinoma of the colon and rectum in a defined population. An epidemiological, clinical and post-mortem investigation of colorectal carcinoma and coexisting benign polyps in Malmö, Sweden. Acta Chir. Scand. 438:1973;1-86. [Supplement].
3. Valone F.H., Kohler M., Fisher K., Hannigan J., Flam M., Gandara D.et al. A northern California oncology group randomized trial of Leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone. NCI Monogr. 5:1987;175-177.
4. Muhiuddin M., Karks G. Adjuvant radiation therapy for colon and rectum cancer. Oncology. 18:1991;11-420.
5. Hill D.J. Neuropeptides and cell proliferation. Daniel E.E. Neuropeptides function in gastrointestinal tract. 1991;479-490 CRC Press, Boca Raton.
6. O'Dorisio M. Neuropeptides and gastrointestinal immunity. Am. J. Med. 81:1987;74-82. [Supplement 6B].
7. El-Salhy M., Norrgård O., Boström A. Low levels of colonic somatostatin and galanin in patients with colon carcinoma. GI Cancer. 2:1998;221-225.
8. El-Salhy M., Mahdavi J., Norrgård Ö. Colonic endocrine cells in patients with carcinoma of the colon. Eur. J. Gastroenterol. Hepatol. 10:1998;517-522.
9. El-Salhy M., Norrgård Ö., Franzén L., Forsgren S. Colonic endocrine cells in patients with carcinoma of the rectum with special regard to preoperative irradiation. GI Cancer. 2:1998;285-292.
10. Weibel E., Elias H. Introduction to stereologic principles. Weibel E., Elias H. Quantitative methods in morphology. 1967;89-98 Springer, Berlin.
11. Weibel E., Stäubli R.H., Hess F.A. Correlated morphometric and biochemical studies on the liver cell: Part I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J. Cell Biol. 42:1969;68-91.
12. Palmqvist R., Öberg Å., Bergström C., Rutegård J.N., Zackrisson B., Stenling R. Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer. Br. J. Cancer. 77:1998;917-925.
13. El-Salhy M., Stenling R., Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand. J. Gastroenterol. 28:1993;809-815.
14. Laemel E., Stücker O., Darmon P.-L., Vicaut E. Characterization of the specific response to serotonin of mouse tumour-feeding arterioles. Int. J. Radiat. Biol. 74:1998;379-386.
15. Alonos M., Galera M.J., Reyes G., Calabuig R., Vinals A., Rius X. Effects of pentagastrin and somatostatin analog (SMS 201-995) on growth of CT26 in vivo adenocarcinoma of the colon. Surg. Gynecol. Obestet. 175:1992;441-444.
16. Gamet L., Murat J.C., Remaury A., Remesy C., Valet P., Paris H.et al. Vasoactive intestinal peptide and forskolin regulate proliferation of HT29 human colon adenocarcinoma cell line. J. Cell. Physiol. 150:1992;501-509.
17. Narayan S., Guo Y.S., Townsend C.M. Jr., Singh P. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro. Cancer Res. 50:1990;6772-6778.
18. Qin Y., Schally A.V., Willems G. Treatment of liver metastases of human colon cancer in nude mice with somatostatin analogue RC-160. Int. J. Cancer. 52:1992;791-796.
19. Radulovic S., Schally A.V., Reile H., Halmos G., Szepeshazi K., Groot K.et al. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of TH-29 human colon cancers in nude mice. Acta Oncol. 33:1994;693-701.
20. Robbins R.J. Somatostin and cancer. Metab. Clin. Exp. 45:1996;98-100.
21. Smith J.P., Solomon T.E. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology. 95:1988;1541-1548.
22. Smith J.P., Doll D., Croitoru R., Thornton C., Peryy M.C. Octreotide has no effect on advanced colon cancer. J. Clin. Gastroenterol. 18:1994;245-247.
23. van-Tol E.A., Verspaget H.W., Pena A.S., Jansen J.B., Aparicio-Pages M.N., Lambers C.B. Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumour cells in vitro. Immunol. Invest. 20:1991;257-267.
24. Winsett O.E., Townsend C.M. Jr., Glass C.J., Thompson J.C. Gastrin stimulates growth of colon cancer. Surgery. 99:1986;302-307.
25. Goldberg R.M., Moertel C.G., Wieand H.S., Krool J.E., Schut A.J., Veeder M.H.et al. A phase III evaluation of somatostatin analogue (octreotise) in the treatment of patients with asymptomatic advanced colon carcinoma. Cancer. 76:1995;961-966.
26. Melen-Mucha G., Winczyk K., Pawlikowski M. Effects of somatostatin analogs octreotide and lanreotide on proliferation and apoptosis in colon 38 tumour: interaction with 5-fluorouracil. Neuro Endocrinol. Lett. 21:2000;137-142.
27. Ferjoux G., Bousquet C., Cordelier P., Benali N., Lopez F., Rochaix P.et al. Signal transduction of somatostatin receptors negatively controlling cell proliferation. J. Physiol., Paris. 94:2000;205-210.
28. Tutton P.J.M., Barkla D.H. The influence of serotonin on the mitotic rate in the colonic crypt epithelium and in colonic adenocarcinoma in rats. Clin. Exp. Pharmacol. Physiol. 5:1978;91-94.
29. Barkla D.H., Tutton P.J.M. Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumours. J. Natl. Cancer Inst. 67:1981;1207-1211.
30. Baguley B.C., Cole G., Thomsen L.L., Li Z. Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthrenone-4-acetic acid. Cancer Chemother. Pharmacol. 33:1993;77-81.
31. Huhnt W., Lubbe A.S. Growth, microvessel density and tumour cell invasion of human colon adenocarcinoma under repeated treatment with hyperthermia and serotonin. J. Cancer Res. Clin. Oncol. 121:1995;423-428.
32. Baguley B.C., Zhuang L., Kestell P. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dmethylxanthrenone-4-acetic acid, vinblastine and colchicine: relation to vascular effect. Oncol. Res. 9:1997;55-60.
33. lishi H., Tatsuta M., Baba M., Uehara H., Yano H., Nakaizumi A. Chemoprevention by galanin against colon carcinogenesis induced by azoxymethane in wistar rats. Int. J. Cancer. 61:1995;861-863.